Four opposition parties jointly submitted a bill Friday to the Lower House that would greatly reduce medical costs that hepatitis B and C patients need to shoulder for expensive interferon treatment and antiviral medication.

Last April, the government started subsidizing the interferon treatment for hepatitis B and C patients after admitting responsibility for approving tainted blood products that further spread the already rampant diseases in Japan.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.